Podcasts about diabetes medications

In this episode of PT Snacks podcast, host Kasey discusses the relationship between exercise and diabetes, specifically aimed at physical therapists and students. The episode covers the different types of diabetes (Type 1, Type 2, and gestational), and how exercise influences blood sugar levels. It also highlights the effects of various diabetes medications on exercise and provides practical tips for safely managing patients with diabetes in a physical therapy setting. Additionally, useful resources and courses are recommended for further learning.00:00 Introduction to PT Snacks Podcast00:46 Understanding Diabetes and Exercise01:47 Types of Diabetes and Their Impact on Exercise03:21 Diabetes Medications and Exercise Considerations04:59 Guidelines for Safe Exercise with Diabetes06:04 Red Flags and Patient Communication06:57 Additional Resources and ConclusionRelevant MedBridge Courses1. Exercise and Drug Interactions – Kenneth L. Miller2. Managing Patients with Diabetes – Kathy Shimp, PT, DPTSupport the showWhy PT Snacks Podcast?This podcast is your go-to for bite-sized, practical info designed for busy, overwhelmed Physical Therapists and students who want to build confidence in their foundational knowledge without sacrificing life's other priorities. Stay Connected! Never miss an episode—hit follow now! Got questions? Email me at ptsnackspodcast@gmail.com or leave feedback HERE. Join the email list HERE On Instagram? Find unique content at @dr.kasey.hankins! Need CEUs Fast?Time and resources short? Medbridge has you covered: Get over $100 off a subscription with code PTSNACKSPODCAST: Medbridge Students: Save $75 off a student subscription with code PTSNACKSPODCASTSTUDENT—a full year of unlimited access for less!(These are affiliate links, but I only recommend Medbridge because it's genuinely valuable.) Optimize Your Patient Care with Tindeq Looking for a reliable dynamometer to enhance your clinical measurements? Tindeq ...

How do GLP-1 receptor agonists and metformin affect glaucoma risk in patients with Type 2 diabetes? Join Dr. Ike Ahmed and Jawad Muayad as they discuss the data on diabetes treatments and glaucoma risk with Dr. Emily Schehlein. From their Ophthalmology article, “Comparative Effects of Glucagon-like Peptide 1 Receptor Agonists and Metformin on Glaucoma Risk in Patients with Type 2 Diabetes.” Comparative Effects of Glucagon-like Peptide 1 Receptor Agonists and Metformin on Glaucoma Risk in Patients with Type 2 Diabetes. Muayad, Jawad et al. Ophthalmology. In press.

Announcing the return of Intelligent Medicine to WOR 710 AM in New York City—its original home where the show debuted in 1988! Which is better—being thin or being fit? Why you shouldn't succumb to pitches for “free” medical devices from Medicare; Does toasting bread make it carcinogenic? Belgium takes lead in protecting the “Anxious Generation” by banning cell phones in schools; The remarkable health benefits of urolithin A (Mitopure®️). 

Are you looking to reduce or even eliminate your diabetes medications? This episode explores the actionable steps you can take to achieve just that. With a focus on practical strategies like diet, exercise, and lifestyle changes, you'll discover how to lower your blood sugar naturally and improve your A1c levels. We provide science-backed guidance on when it's safe to start reducing medications, and offer  insights on how to have that important conversation with your doctor. If you've ever wondered whether it's possible to manage your diabetes without relying on medications, this episode will show you how.CHAPTERS1:59 Over-reliance on prescribing diabetes medication5:28 Getting off medications, is not only possible, but often beneficial8:13 When to consider getting off medications10:27 How to get off diabetes medications17:23 Methods to get off medicationsFor show notes and resources, please visit: https://Type2DiabetesTalk.comTo share your questions and suggestions, leave us a voice message or email at: https://Type2DiabetesTalk.com/messageExplore our proven programs and services, visit: https://Type2DiabetesTalk.com/programsSubscribe to our free weekly newsletter for podcast updates, valuable nutrition tips and more: https://Type2DiabetesTalk.com/subscribe

Send us a message with this link, we would love to hear from you. Standard message rates may apply.This episode breaks down the different medications used to treat type 2 diabetes, helping patients better understand their treatment options and how these medications work in the body. From metformin to insulin and everything in between, we'll cover the mechanisms, benefits, and potential side effects of each medication class, empowering you to have more informed conversations with your healthcare provider.Support the showProduction and Content: Edward Delesky, MD & Nicole Aruffo, RNArtwork: Olivia Pawlowski

DOWNLOAD THE FASTING TRANSFORMATION JOURNAL HERE! In today's episode of the "Fasting for Life" podcast, we discuss the use of intermittent fasting as a lifestyle intervention for managing and potentially reversing type 2 diabetes. We highlight a recent study comparing the outcomes of a 5:2 meal replacement fasting group to those on metformin or Jardiance, demonstrating superior results in the fasting group for glucose control, weight loss, and reduced side effects. The practical takeaway is emphasizing small, manageable lifestyle changes rather than extreme measures to achieve sustainable health improvements. We encourage listeners to consider integrating intermittent fasting and deliberate meal choices into their lives for long-term wellness benefits. FREE RESOURCE - DOWNLOAD THE NEW  BLUEPRINT TO FASTING FOR FAT LOSS! Learn how to RAMP UP into longer fasting windows! Gain insights into the non-weight loss benefits of fasting! Personalize your own fasting schedule and consistent FAT LOSS results! Get answers to what breaks a fast, how to break a fast, and tips and tricks to accelerate your fasting wins! THE BLUEPRINT TO FASTING FOR FAT LOSS DOWNLOAD Get your FREE BOX OF LMNT hydration support for the perfect electrolyte balance for your fasting lifestyle with your first purchase here! Get 30% off a Keto-Mojo blood glucose and ketone monitor (discount shown at checkout)! Click here! Let's continue the conversation. Click the link below to JOIN the Fasting For Life Community, a group of like-minded, new, and experienced fasters! The first two rules of fasting need not apply! Fasting For Life Community - Join HERE New to the podcast and wondering where to start? Head to the website and download our  Fast Start Guide, 6 simple steps to put One Meal a Day Fasting (OMAD) into practice! Get our NEW sleep guide here! SLEEP GUIDE DIRECT DOWNLOAD If you enjoy the podcast, would you please tap on the stars below and consider leaving a short review on Apple Podcasts/iTunes? It takes less than 60 seconds, and it helps bring you the best original content each week. We also enjoy reading them! Research Links:

Renu Rayasam KFF Health News Senior Correspondent joins Megan Lynch to explain the high costs.

You are out there reversing your diabetes using the most powerful lifestyle strategies I teach here on this podcast, and you're wondering, "When do I call my doctor to see if I can stop my diabetes medications?"This podcast episode breaks down why you might want to do this, how to know when it's time, and what to  do to make it happen.  As a clinical pharmacist and diabetes reversal coach, I cover all the juicy details so that you know what you need to know to liberate yourself from a lifetime of taking meds.Work With Sarah

This episode marks the final installment of our Medication March series, where we've been empowering you to take control of your diabetes health. This journey has been about more than just understanding medications; it's about equipping you with the knowledge to make informed health decisions and to have the all important conversation about medications with your doctor and healthcare team.Today, we delve into the effectiveness of various glucose-lowering medications, revisit the importance of knowing the risks versus benefits, and discuss overtreatment and overprescription of meds. Most importantly, we explore the concept of deprescribing, including the evidence on deprescribing in type 2 diabetes and prediabetes. It's crucial for you to understand that while diabetes medications can play a role, a healthy lifestyle, particularly nutrition, often has a more significant impact on your diabetes management.You might be wondering if it's possible to reduce or even stop certain diabetes medications. The answer is yes. Deprescribing, especially for those with stable or low A1c levels ≤7%, can be a beneficial strategy, as the evidence clearly describes. Although there are obstacles in the healthcare system, you are at the center of your own diabetes health. Remember, every visit to your doctor is an opportunity for you to take charge. Ask about your medications and whether any can be reduced or eliminated. If a new medication is suggested, inquire about its necessity and possible alternatives.By being proactive and informed. Stay empowered and remember, you're not alone in this journey!Please get involved in this conversation!Visit Type2DiabetesTalk.com and leave your comments on any of the Medication March episodes (and it doesn't have to be during March!), or leave us a voice message or send an email with your questions and experiences. CHAPTERS0:00 Medication March Ground Covered3:21 Glucose-Lowering Medications6:35 Healthy Lifestyle & Limited Effect of Meds9:42 Do The Risks Outweigh The Benefits?11:49 Has Diabetes Become Overmedicalized?13:36 Deprescribing Facts18:32 Is It Really Possible To Stop Diabetes Medications?21:55 Methods For Deprescribing22:39 Have The Medication Conversation With Your DoctorFor show notes and resources, please visit: https://Type2DiabetesTalk.comTo share your questions and suggestions, leave us a voice message or email at: https://Type2DiabetesTalk.com/messageExplore our proven programs and services, visit: https://Type2DiabetesTalk.com/programsSubscribe to our free weekly newsletter for podcast updates, valuable nutrition tips and more: https://Type2DiabetesTalk.com/subscribe

Does nirmatrelvir reduce the risk of developing long COVID? Find out about this and more in today's PV Roundup podcast.

In this crossover episode of BackTable OBGYN with Urology, Dr. Suzette Sutherland, Director of Female Urology at the University of Washington, and Dr. Anne Cameron, Professor of Urology at the University of Michigan, share their insights on the prevention and management of urinary tract infections (UTIs). First, they emphasize the importance of dispelling misconceptions about recurrent UTIs being a result of poor hygiene or incorrect behaviors, explaining that they can stem from genetic or hormonal risk factors. Dr. Cameron describes her algorithm for managing UTIs in specific patient populations. She further discusses the impact of factors such as fluid intake, bowel habits, and vaginal health on the incidence of UTIs. Dr. Cameron also highlights the potential for UTIs in diabetic patients on certain medications and the importance of a collaborative approach with diabetic healthcare teams. Additionally, the doctors explore various treatment strategies, such as cranberry supplements and gentamicin bladder installations, cautioning against antibiotic overuse due to the risk of resistance. --- EARN CME Reflect on how this Podcast applies to your day-to-day and earn free AMA PRA Category 1 CMEs: https://earnc.me/2P5fzK --- SHOW NOTES 00:00 - Introduction 02:13 - Understanding UTIs: Definitions, Symptoms, and Prevalence 04:39 - Recurrent UTIs: Definitions, Causes, and Treatment Challenges 12:00 - Understanding Asymptomatic Bacteriuria 15:00 - Cystitis vs. Pyelonephritis vs. Urosepsis 20:57 - Antimicrobial Resistance and Antibiotic Stewardship 24:36 - Treatment Guidelines for UTIs 31:13 - Self-start Antibiotic Therapy for UTIs 34:37 - Preventing UTIs: Hydration, Lifestyle Factors, and Bowel Health 38:33 - The Connection Between Vaginal Health and UTIs 42:40 - The Role of Supplements in UTI Prevention: D-Mannose and Cranberry, and Methenamine Hippurate 57:18 - Identification and Treatment of UTIs in Patients with Indwelling Catheters 01:00:04 - The Role of Gentamicin Bladder Installations in UTI Prevention 01:04:27 - The Impact of Diabetes Medications on UTIs --- RESOURCES AUA Guidelines for UTI Treatment: https://www.auanet.org/guidelines-and-quality/guidelines/recurrent-uti

In this crossover episode of BackTable OBGYN with Urology, Dr. Suzette Sutherland, Director of Female Urology at the University of Washington, and Dr. Anne Cameron, Professor of Urology at the University of Michigan, share their insights on the prevention and management of urinary tract infections (UTIs). First, they emphasize the importance of dispelling misconceptions about recurrent UTIs being a result of poor hygiene or incorrect behaviors, explaining that they can stem from genetic or hormonal risk factors. Dr. Cameron describes her algorithm for managing UTIs in specific patient populations. She further discusses the impact of factors such as fluid intake, bowel habits, and vaginal health on the incidence of UTIs. Dr. Cameron also highlights the potential for UTIs in diabetic patients on certain medications and the importance of a collaborative approach with diabetic healthcare teams. Additionally, the doctors explore various treatment strategies, such as cranberry supplements and gentamicin bladder installations, cautioning against antibiotic overuse due to the risk of resistance. --- EARN CME Reflect on how this Podcast applies to your day-to-day and earn free AMA PRA Category 1 CMEs: https://earnc.me/2P5fzK --- SHOW NOTES 00:00 - Introduction 02:13 - Understanding UTIs: Definitions, Symptoms, and Prevalence 04:39 - Recurrent UTIs: Definitions, Causes, and Treatment Challenges 12:00 - Understanding Asymptomatic Bacteriuria 15:00 - Cystitis vs. Pyelonephritis vs. Urosepsis 20:57 - Antimicrobial Resistance and Antibiotic Stewardship 24:36 - Treatment Guidelines for UTIs 31:13 - Self-start Antibiotic Therapy for UTIs 34:37 - Preventing UTIs: Hydration, Lifestyle Factors, and Bowel Health 38:33 - The Connection Between Vaginal Health and UTIs 42:40 - The Role of Supplements in UTI Prevention: D-Mannose and Cranberry, and Methenamine Hippurate 57:18 - Identification and Treatment of UTIs in Patients with Indwelling Catheters 01:00:04 - The Role of Gentamicin Bladder Installations in UTI Prevention 01:04:27 - The Impact of Diabetes Medications on UTIs --- RESOURCES AUA Guidelines for UTI Treatment: https://www.auanet.org/guidelines-and-quality/guidelines/recurrent-uti

In the United States, nearly three-quarters of adults qualify as overweight or obese, 42% of whom are considered obese. The World Obesity Federation predicts that 51% of the global population will be overweight or obese by 2035. ‘Fast Company' contributing writer Adam Bluestein joined us to break down how Novo Nordisk, the company behind Ozempic and Wegovy, developed and marketed its weight-loss drugs. He also explained why the drugs have become so popular in the U.S., how drug pricing is extremely complicated and . . . how the medications actually work to help people lose weight. Also, we chatted with Trina Spear about how she founded Figs, a DTC healthcare apparel company.

In the United States, nearly three-quarters of adults qualify as overweight or obese, 42% of whom are considered obese. The World Obesity Federation predicts that 51% of the global population will be overweight or obese by 2035. ‘Fast Company' contributing writer Adam Bluestein joined us to break down how Novo Nordisk, the company behind Ozempic and Wegovy, developed and marketed its weight-loss drugs. He also explained why the drugs have become so popular in the U.S., how drug pricing is extremely complicated and . . . how the medications actually work to help people lose weight. Also, we chatted with Trina Spear about how she founded Figs, a DTC healthcare apparel company.

In the United States, nearly three-quarters of adults qualify as overweight or obese, 42% of whom are considered obese. The World Obesity Federation predicts that 51% of the global population will be overweight or obese by 2035. ‘Fast Company' contributing writer Adam Bluestein joined us to break down how Novo Nordisk, the company behind Ozempic and Wegovy, developed and marketed its weight-loss drugs. He also explained why the drugs have become so popular in the U.S., how drug pricing is extremely complicated and . . . how the medications actually work to help people lose weight. Also, we chatted with Trina Spear about how she founded Figs, a DTC healthcare apparel company.

Today On Medical Grounds, we will be speaking with Dr. Heather Whitley. Dr. Whitley is a clinical professor in the Department of Pharmacy Practice at the Auburn University Harrison College of Pharmacy. She is a board certified pharmacotherapy specialist and a certified diabetes educator. Earlier this year, Dr. Whitley spoke with us about screening for diabetes in high-risk individuals. Today, she is back to talk about some new things going on in the diabetes and pharmacy world. This is part 1 of a two part series. In Part 1, Dr. Whitley will be discussing shortages in GLP-1 agonist drugs for diabetes and what pharmacists can do to address those shortages.Dr. Whitley recently published a paper in Clinical Diabetes about this topic:Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages(00:09) Introduction to Dr. Whitley(01:08) Publication on strategies for GLP-1 and GLP-1/GIP shortages(02:36) GLP-1 and GLP-1/GIP agonists, names, and dosing(04:15) Why are there shortages?(08:52) Alternatives(10:11) What happens if a patient misses a dose?(12:19) Re-initiation of medications(14:51) GLP-1 agonist equivalency(15:31) Substituting SGLT2s(17:16) Self-sourcing or online sourcing problems(21:51) Managing patient expectations and concernsVisit us at OnMedicalGrounds.com for more podcasts! You can subscribe through your podcast platform, our website, or follow us on social media for podcast updates and medical news. Some of our podcasts offer FREE CME/CE credits.LinkTreeTwitterLinkedInInstagram

In this journal club episode, my guest is Stanford and Johns Hopkins-trained physician, Dr. Peter Attia, M.D., who is also the host of The Drive podcast and the author of the bestselling book "Outlive: The Science & Art of Longevity." We each present a scientific paper and discuss the findings' strengths, weaknesses and actionable takeaways. First, we discuss an article that addresses whether taking the drug metformin can enhance longevity. Then, we discuss an article on belief effects (similar to placebo effects), showing how the effects of a drug on the brain and cognition depend on one's belief about the dose of the drug taken, not the actual dose. Our conversation also highlights how to read, interpret and critique scientific studies. This episode ought to be of interest to those curious about health and longevity, medicine and psychology and for anyone seeking to better understand how to read and digest scientific findings. For the full show notes, including articles, books, and other resources, visit hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman Helix Sleep: https://helixsleep.com/huberman Levels: https://levels.link/huberman InsideTracker: https://insidetracker.com/huberman Momentous: https://livemomentous.com/huberman Timestamps 00:00:00 Dr. Peter Attia, Journal Club 00:03:27 Sponsors: Helix Sleep & Levels 00:06:11 Dreams 00:12:36 Article #1, Metformin, Mitochondria, Blood Glucose 00:19:47 Type 2 Diabetes & Causes, Insulin Resistance 00:25:30 Type 2 Diabetes Medications, Metformin, Geroprotection, Bannister Study 00:36:19 Sponsor: AG1 00:37:15 TAME Trial; Demographics, Twin Cohort 00:44:27 Metformin & Mortality Rate 00:51:28 Kaplan-Meier Mortality Curve, Error Bars & Significance, Statistical Power 01:01:17 Sponsor: InsideTracker 01:02:23 Hazard Ratios, Censoring 01:09:00 Metformin Advantage?, Variables, Interventions Testing Program 01:16:02 Berberine, Acarbose, SGLT2 Inhibitors 01:23:48 Blood Glucose & Energy Balance; Caloric Restriction, Aging Biomarkers 01:32:22 Tool: Reading Journal Articles, 4 Questions, Supplemental Information 01:38:10 Article #2, Belief Effects vs. Placebo Effect 01:45:22 Nicotine Effects 01:51:07 Nicotine Doses & Belief Effects, fMRI Scan 02:00:07 Biological Effects, Dose-Dependent Response & Belief Effects 02:05:14 Biology & Beliefs, Significance, Dopamine Response, Non-Smokers 02:10:57 Dose-Dependence & Beliefs, Side Effects, Nocebo Effect 02:19:06 Zero-Cost Support, YouTube Feedback, Spotify & Apple Reviews, Sponsors, Momentous, Neural Network Newsletter, Social Media Title Card Photo Credit: Mike Blabac Disclaimer

In this episode, we discuss the common misconceptions surrounding prescribing GLP1 medications such as Ozempic, Victoza, and Mounjaro, which were initially designed to treat type 2 diabetes and are now being prescribed to treat the disease of obesity. Dr. Michael Albert, an obesity specialist, joins us to set the record straight. Support the showKim Carlos @DMFKimonMounjaro on TikTokJernine Trott @TheeJernine on TikTokKat Carter @KatCarter7 on TikTokLydia Roberts @mounjaro_GLP_Help on TikTok

Thomas Blevins, MD, an Endocrinologist from Texas Diabetes and Endocrinology in Austin, TX, joins The Huddle to talk about interchangeable biosimilar insulin. We discuss what interchangeability means and the evidence supporting it. You'll also hear about the options interchangeable biosimilar insulin presents for healthcare systems and people with diabetes.This episode is sponsored by ViatrisResourcesWebinar on Interchangeable Biosimilar Insulin (Free and non-CE):  The New Frontier of Interchangeable Biosimilar Insulins  - bit.ly/3vxUWZ1Tip Sheets on Interchangeable Biosimilar Insulin in English Viatris_Tip_Sheet_v3_04202022 (diabeteseducator.org) and Spanish Viatris_Tip_Sheet_v3_04202022_spa (diabeteseducator.org)Insulin delivery resources from ADCES: www.DiabetesEducator.org/InsulinBlevins, T. C., Barve, A., Raiter, Y., Aubonnet, P., Athalye, S., Sun, B., & Muniz, R. (2020). Efficacy and safety of MYL-1501D versus insulin glargine in people with type 1 diabetes mellitus: Results of the INSTRIDE 3 phase 3 switch study. Diabetes, obesity & metabolism, 22(3), 365–372. https://doi.org/10.1111/dom.13904Viatris website: http://www.viatris.com

Welcome back to the show, Dr. Jake Rickoll.Phil and Dr. Rickoll breakdown the diabetes medications, Ozempic and Mounjaro. The medications being used for ther weightloss effects.This episode breaks down:What these drugs doHow they workBenefitsSide EffectsWho they are forAccessibilty such as Price and Insurance Coverage and much moreDon't forget to subscribe and leave a review

In this week's podcast we chat with Olga Lutzko, Nurse Practitioner from Succeed in Diabetes, about:Cannabis and diabetesDoctors vs nurse practitionersPatient tendencies in cannabisSucceed in Diabetes:https://succeedindiabetes.com.au/AltMed:https://altmed.com.au/

In this episode we will be covering Facebook Live Questions 9/19-9/25/22. For the latest updates visit my blog and be sure to join the free Facebook Group Registered Dietitian Exam Study Group with Dana RD! Grab the free RD Exam Prep Class here.  Looking for additional tutoring service? Visit my website!

The Blood Sugar Level Needed To Remove Diabetes Medications - Baxter Montgomery, MD - Interview Baxter Montgomery, M.D. • https://montgomeryheart.com/• Book - The Food Prescription for Better Health: A Cardiologists Proven Method to Reverse Heart Disease, Diabetes, Obesity, and Other Chronic Illnesses Naturally! Dr. Baxter D. Montgomery is a Board Certified Cardiologist with years of experience in the latest medical practices and nutritional health. He is a Clinical Assistant Professor of Medicine in the Division of Cardiology at the University of Texas in Houston, a Fellow of the American College of Cardiology (FACC) and the founder and president of the Houston Cardiac Association (HCA). Having seen many patients suffer the consequences of chronic heart disease, Dr. Montgomery founded the Montgomery Heart & Wellness Center in 2006 with the mission to reverse and prevent life-threatening illnesses. Located in Houston, Texas, The Montgomery Heart & Wellness Center is a state-of-the-art wellness facility complete with all the technology and resources to provide comprehensive medical and wellness care. Combining his medical practice with a food-driven lifestyle intervention, Dr. Montgomery introduces patients to a novel food classification system that helps reverse chronic conditions such as heart disease, hypertension, obesity and diabetes without medications or surgeries. He has refined this process over the past 10 years with profound positive results in severely ill patients. In addition to running Montgomery Heart & Wellness, Dr. Montgomery manages arrhythmias and coronary disease, performs angiographies, defibrillator implants and other hospital procedures, and teaches young physicians. Dr. Montgomery earned his undergraduate degree from Rice University in Houston and his Medical Degree from The University of Texas Medical Branch in Galveston, Texas. He is also the author of The Food Prescription for Better Health, a comprehensive guide for reversing chronic illnesses. #BaxterMontgomery #TheRealTruthAboutHealth  #HeartDisease #PlantBasedNutrition #DiseasePrevention #IntermittentFasting CLICK HERE - To Checkout Our MEMBERSHIP CLUB: http://www.realtruthtalks.com  • Social Media ChannelsFacebook: https://www.facebook.com/TRTAHConferenceInstagram : https://www.instagram.com/therealtruthabouthealth/ Twitter: https://twitter.com/RTAHealth Linkedin: https://www.linkedin.com/company/the-real-truth-about-health-conference/ Youtube: https://www.youtube.com/c/TheRealTruthAboutHealth    • Check out our Podcasts  Visit us on Apple Podcast and Itunes search:  The Real Truth About Health Free 17 Day Live Online Conference Podcast Amazon: https://music.amazon.com/podcasts/23a037be-99dd-4099-b9e0-1cad50774b5a/real-truth-about-health-live-online-conference-podcastSpotify: https://open.spotify.com/show/0RZbS2BafJIEzHYyThm83J Google:https://www.google.com/podcasts?feed=aHR0cHM6Ly9mZWVkcy5zaW1wbGVjYXN0LmNvbS8yM0ZqRWNTMg%3D%3DStitcher: https://www.stitcher.com/podcast/real-truth-about-health-live-online-conference-podcastAudacy: https://go.audacy.com/partner-podcast-listen-real-truth-about-health-live-online-conference-podcastiHeartRadio: https://www.iheart.com/podcast/269-real-truth-about-health-li-85932821/ Deezer: https://www.deezer.com/us/show/2867272 Reason: https://reason.fm/podcast/real-truth-about-health-live-online-conference-podcast • Other Video ChannelsYoutube:https://www.youtube.com/c/TheRealTruthAboutHealthVimeo:https://vimeo.com/channels/1733189Rumble:  https://rumble.com/c/c-1111513 Facebook:https://www.facebook.com/TRTAHConference/videos/?ref=page_internal DailyMotion: https://www.dailymotion.com/TheRealTruthAboutHealth BitChute:https://www.bitchute.com/channel/JQryXTPDOMih/ Disclaimer:Medical and Health information changes constantly. Therefore, the information provided in this podcast should not be considered current, complete, or exhaustive. Reliance on any information provided in this podcast is solely at your own risk. The Real Truth About Health does not recommend or endorse any specific tests, products, procedures, or opinions referenced in the following podcasts, nor does it exercise any authority or editorial control over that material. The Real Truth About Health provides a forum for discussion of public health issues. The views and opinions of our panelists do not necessarily reflect those of The Real Truth About Health and are provided by those panelists in their individual capacities. The Real Truth About Health has not reviewed or evaluated those statements or claims. 

Using Fasting To Get People Off Diabetes Medications In 3 Days To A Week - Gabriel Cousens, MD - Interview Gabriel Cousens, MD, MD(H), DD • http://treeoflifecenterus.com/• Book - There Is a Cure for Diabetes, Revised Edition: The 21-Day+ Holistic Recovery Program Gabriel Cousens is the author of thirteen internationally acclaimed books including Spiritual Nutrition and Creating Peace by Being Peace. Known worldwide as a spiritual teacher and the leading expert in live, plant-source nutrition, Dr. Cousens functions as a holistic physician, psychiatrist, family therapist, and cutting-edge researcher on healing diabetes naturally. He holds an M.D. from Columbia Medical School, a doctorate in homeopathy, and diplomas in Ayurveda, clinical acupuncture, and holistic medicine. His multicultural background as an ordained rabbi, an acknowledged yogi, and a four-year Native American Sundancer, adds insight to his “whole-person enlightenment” teachings. Dr. Cousens is the founder and director of the Tree of Life Foundation. #GabrielCousens #TheRealTruthAboutHealth  #WholeFood #Vegan #Vegetarian #PlantBasedNutrition #LiveFood CLICK HERE - To Checkout Our MEMBERSHIP CLUB: http://www.realtruthtalks.com  • Social Media ChannelsFacebook: https://www.facebook.com/TRTAHConferenceInstagram : https://www.instagram.com/therealtruthabouthealth/ Twitter: https://twitter.com/RTAHealth Linkedin: https://www.linkedin.com/company/the-real-truth-about-health-conference/ Youtube: https://www.youtube.com/c/TheRealTruthAboutHealth    • Check out our Podcasts  Visit us on Apple Podcast and Itunes search:  The Real Truth About Health Free 17 Day Live Online Conference Podcast Amazon: https://music.amazon.com/podcasts/23a037be-99dd-4099-b9e0-1cad50774b5a/real-truth-about-health-live-online-conference-podcastSpotify: https://open.spotify.com/show/0RZbS2BafJIEzHYyThm83J Google:https://www.google.com/podcasts?feed=aHR0cHM6Ly9mZWVkcy5zaW1wbGVjYXN0LmNvbS8yM0ZqRWNTMg%3D%3DStitcher: https://www.stitcher.com/podcast/real-truth-about-health-live-online-conference-podcastAudacy: https://go.audacy.com/partner-podcast-listen-real-truth-about-health-live-online-conference-podcastiHeartRadio: https://www.iheart.com/podcast/269-real-truth-about-health-li-85932821/ Deezer: https://www.deezer.com/us/show/2867272 Reason: https://reason.fm/podcast/real-truth-about-health-live-online-conference-podcast • Other Video ChannelsYoutube:https://www.youtube.com/c/TheRealTruthAboutHealthVimeo:https://vimeo.com/channels/1733189Rumble:  https://rumble.com/c/c-1111513 Facebook:https://www.facebook.com/TRTAHConference/videos/?ref=page_internal DailyMotion: https://www.dailymotion.com/TheRealTruthAboutHealth BitChute:https://www.bitchute.com/channel/JQryXTPDOMih/ Disclaimer:Medical and Health information changes constantly. Therefore, the information provided in this podcast should not be considered current, complete, or exhaustive. Reliance on any information provided in this podcast is solely at your own risk. The Real Truth About Health does not recommend or endorse any specific tests, products, procedures, or opinions referenced in the following podcasts, nor does it exercise any authority or editorial control over that material. The Real Truth About Health provides a forum for discussion of public health issues. The views and opinions of our panelists do not necessarily reflect those of The Real Truth About Health and are provided by those panelists in their individual capacities. The Real Truth About Health has not reviewed or evaluated those statements or claims. 

Should we use oral diabetes agents in our hospitalized patients? Do you hold metformin for fear of lactic acidosis? Do you typically order an insulin sliding scale? When can you comfortably restart PTA meds?Time Stamps:02:25 Can we give metformin in the hospital?10:50 Incretin-based therapies14:49 Sodium Glucose Cotransporter-2 Inhibitors16:27 Sulfonylurea & Thiazolidinediones18:00 Basal Insulin inpatientShow notes, Transcript and References: https://www.coreimpodcast.com/2021/10/13/oral-diabetes-medications-in-hospitalization-mind-the-gap-segment/ACP CME: https://www.acponline.org/cme-moc/cme/internal-medicine-podcasts/core-im Tags: Core IM, IM Core, glucose, insulin, hospitalized patients, oral medications, sliding scale, DPP-4, GLP-1

Today, Dr. Ward will be discussing the importance of insulin and the role it plays in the vital functioning of the body as well as treating diabetes! He will also be discussing the different types of insulin and how they work! if you are struggling with your diabetes, email me or contact me through the website, but please, reach out to me. I want to help you take control of your diabetes and still enjoy a life you love! The two are not mutually exclusive! Email me at succeedingwithdiabetes@gmail.com or reach me through the website www.succeedingwithdiabetes.com If you are overwhelmed and not sure what and how you should eat, then get your FREE copy of my Diabetes Meal Planning Guide at https://pages.succeedingwithdiabetes.com! It will help answer those questions and many more! This guide will help you kick start your Meal Plan!

Today, Dr. Ward discusses oral diabetes medications and how they work! Join us to learn more about your medications and how they work to lower your blood sugar readings! Also, if you are struggling with your diabetes, email me or contact me through the website, but please, reach out to me. I want to help you take control of your diabetes and still enjoy a life you love! The two are not mutually exclusive! Email me at succeedingwithdiabetes@gmail.com or reach me through the website www.succeedingwithdiabetes.com Also get a FREE copy of my Diabetes Meal Planning Guide at https://pages.succeedingwithdiabetes.com! This guide will help you kick start your Meal Plan!

Sign up for DSME For more information on how to manage your diabetes sign up for a diabetes education program. Go to diabetes.org/diabetes/find-a-program to find a program near you.

When clients come to me, they are often on all sorts of diabetes medications. As we work together to make lifestyle changes, these medications need to be adjusted. Ideally, if you can make lifestyle changes and reverse your type 2 diabetes, these medications can be eliminated. During this podcast, I discuss the many diabetes medications on the market, their benefits and side effects. As with all my podcasts, the content is for information only and not intended as medical advice or treatment. I always recommend working with a primary care physician to manage your diabetes and diabetes medications.

Are you a woman of color, looking for ways to connect to other women of color with diabetes? Listen into Cherise's personal experience and connect with her or other women of color navigating their way through everyday diabetes challenges!Connect with WOCdiabetesInstagram: @WOCdiabetesTwitter: @WOCdiabetesFacebook @WOCdiabetesLooking for one-on-one diabetes support? Want to learn how to manage diabetes without fixating on weight? Need a "one-and-done" check in to see how your diabetes management plan is working? Check out my consultation options!Make sure you subscribe to this podcast AND Type2andYou. As a big thank you, I'll send you a FREE copy of my 5-Strategy Guide for Building Your Diabetes Confidence!Every person with diabetes is unique and deserves care tailored to them by a medical team directly involved in their diabetes care. For that reason, this podcast & Type2andYou content is for informational purposes only and not intended as medical advice. You can read my complete disclaimer on Type2andYou.org.

Curious about one of the newer classes of T2D medications? You may have seen or read about some of them, including: Januvia, Onglyza, Nesina, Tradjenta. Learn how these medications work, tips for combating side effects (HINT: there are very few!), and if these medications have the same the positive impact on your heart as other diabetes groups. Make sure you subscribe to this podcast AND Type2andYou. As a big thank you, I'll send you a FREE copy of my 5-Strategy Guide for Building Your Diabetes Confidence!Diabetes Dilemmas (Q&A):I answer a Diabetes Dilemma question on "time in range," including how you can calculate this if you don't use a continuous glucose monitor. Check out my chat with T'ara from Beyond Type 2 on CGMs and time in range here!Have a Diabetes Dilemma? Ask Me HERE!Or, find me on:Facebook: https://www.facebook.com/Type2andYouwithMeg/Instagram: https://www.instagram.com/type2andyou_by_a_cde/Twitter: https://twitter.com/Type2andYouCDEEvery person with diabetes is unique and deserves care tailored to them by a medical team directly involved in their diabetes care. For that reason, this podcast & Type2andYou content is for informational purposes only and not intended as medical advice. You can read my complete disclaimer on Type2andYou.org.

Diabetes medications can help you control your blood sugar levels and prevent diabetes-related complications. To receive more tips on how to manage your diabetes sign up for ADA’s free Living With Type 2 Diabetes Program. 

Thanks for tuning in to the Armor Men's Health Hour Podcast today, where we bring you the latest and greatest in urology care and the best urology humor out there.In this segment Dr. Mistry and Donna Lee are joined by Dr. Kerem Ozer from Texas Diabetes and Endocrinology. They discuss the different classes of medication available to treat both Type 1 and Type 2 diabetes. If you or a loved one have been diagnosed with pre diabetes or diabetes and would like more information, please contact Dr. Ozem at Texas Diabetes and Endocrinology. They have three offices in the Austin area: South Austin, Central Austin, Round Rock. Their phone number is (512) 458-8400, and their website is www.texasdiabetes.com. If you enjoyed today's episode, don't forget to like, subscribe, and share us with a friend! As always, be well! Dr. Mistry is a board-certified urologist and has been treating patients in the Austin and Greater Williamson County area since he started his private practice in 2007.We enjoy hearing from you! Email us at armormenshealth@gmail.com and we'll answer your question in an upcoming episode!Phone: (512) 238-0762Email: Armormenshealth@gmail.comWebsite: Armormenshealth.comOur Locations:Round Rock Office970 Hester's Crossing Road Suite 101 Round Rock, TX 78681South Austin Office6501 South Congress Suite 1-103 Austin, TX 78745Lakeline Office12505 Hymeadow Drive Suite 2C Austin, TX 78750Dripping Springs Office170 Benney Lane Suite 202 Dripping Springs, TX 78620

Topic: The Nitty Gritty on GLP-1 MedicationsCurious about one of the newer classes of T2D medications? You may have seen or read about some of them, including: Ozempic, Rybelsus, Trulicity, Victoza, Byetta, Bydureon. Learn how these medications work, tips for combating side effects, and the positive impact many of these medications have on protecting your heart.Need a visual of GLP-1 benefits and risks? Check out my GLP-1 Medication Sheet!Dietitian/Certified Diabetes Care and Education Specialists Resources for Today's Diabetes Dilemma:Bonnie R. Giller, MS, RDN, CDN, CDE, BRG Dietetics & Nutrition, P.C.www.brghealth.comhttps://brghealth.com/healthy-living-diabetes/Bonnie's free eBook: https://brghealth.com/5keysebookErin Phillips, MPH, RD, CDE, Erin Phillips Nutrition, LLC.www.erinphillipsnutrition.comDiabetes Dilemmas (Q&A):I answer a Diabetes Dilemma question on how to combat feeling guilty around food choices.Have a Diabetes Dilemma? Ask Me HERE!Or, find me on:Facebook: https://www.facebook.com/Type2andYouwithMeg/Instagram: https://www.instagram.com/type2andyou_by_a_cde/Twitter: https://twitter.com/Type2andYouCDETake Away of The Day:I give recommendations on how to turn today's topic into action. Find additional resources and supportive tools on Type2andYou.Org.

Episode 282 brings you the COMPLETE guide on metformin! Every possible interaction, MoA, and question has been answered and summarized here on this episode! My goal for this is to truly summarize the full picture of metformin as too many people demonize it for reasons that literally are so insignificant, they should barely even be paid a notice. So with that in mind, get your notepads ready, this one is FULL of information! And yes, a few references for those of you that wish to read further!   REFERENCES 1. Lamanna C, Monami M, Marchionni N, Mannucci E. Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials. Diabetes Obes Metab. 2011;13(3):221–228. [PubMed] 2. Franciosi M, Lucisano G, Lapice E, Strippoli GF, Pellegrini F, Nicolucci A. Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review. PLoS One. 2013;8(8):e71583. [PMC free article] [PubMed] 3. Cohen RD, Woods HF. Clinical and biochemical aspects of lactic acidosis. Philadelphia: Blackwell Scientific Publications; 1976. 4. Metformin hydrochoride. Boxed warning. [October 6, 2015]. Available at: https://dailymed​.nlm​.nih.gov/dailymed/fda/fdaDrugXsl​.cfm?setid​=b8004451-7b26-425b-b5ea-cbb1b08e30e3&type=display. 5. Inzucchi SE, Lipska KJ, Mayo H, Bailey CJ, McGuire DK. Metformin in patients with type 2 diabetes and kidney disease: a systematic review. JAMA. 2014;312(24):2668–2675. [PMC free article] [PubMed] 6. Gan SC, Barr J, Arieff AI, Pearl RG. Biguanide-associated lactic acidosis. Case report and review of the literature. Arch Intern Med. 1992;152(11):2333–2336. [PubMed] 7. Goergen SK, Rumbold G, Compton G, Harris C. Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin. Radiology. 2010;254(1):261–269. [PubMed] 8. Kajbaf F, Arnouts P, de Broe M, Lalau JD. Metformin therapy and kidney disease: a review of guidelines and proposals for metformin withdrawal around the world. Pharmacoepidemiol Drug Saf. 2013;22(10):1027–1035.[PubMed] 9. Calabrese AT, Coley KC, DaPos SV, Swanson D, Rao RH. Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy. Arch Intern Med. 2002;162(4):434–437. [PubMed] 10. Emslie-Smith AM, Boyle DI, Evans JM, Sullivan F, Morris AD. Contraindications to metformin therapy in patients with Type 2 diabetes--a population-based study of adherence to prescribing guidelines. Diabet Med. 2001;18(6):483–488. [PubMed] 11. U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function. [June 16, 2016]. Available at: http://www​.fda.gov/Drugs​/DrugSafety/ucm493244.htm. 12. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function—measured and estimated glomerular filtration rate. N Engl J Med. 2006;354(23):2473–2483. [PubMed] 13. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabtologia. 2015;58(3):429–442. [PubMed] 14. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. Am J Kidney Dis. 2012;60(5):850–886. [PubMed] 15. Flory JH, Hennessy S. Metformin use reduction in mild to moderate renal impairment: possible inappropriate curbing of use based on food and drug administration contraindications. JAMA Intern Med. 2015;175(3):458–459. [PubMed] 16. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2010;(4) CD002967. [PubMed] 17. Organization for Economic Cooperation and Development. [October 20, 2015]. Available at: http://www​.oecd.org/about​/membersandpartners​/list-oecd-member-countries.htm. 18. Eurich DT, Weir DL, Majumdar SR, et al. Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients. Circ Heart Fail. 2013;6(3):395–402. [PubMed] 19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461–470. [PubMed] 20. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. [PMC free article] [PubMed] 21. Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. [PMC free article] [PubMed] 22. Agency for Healthcare Research and Quality. Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Rockville, MD: Agency for Healthcare Research and Quality; [October 6, 2015]. Available at: http://www​.effectivehealthcare​.ahrq.gov/index​.cfm/search-for-guides-reviews-and-reports​/?pageaction=displayproduct&productid=318. 23. Santaguida PL, Raina P, Ismaila P. The Development of the McHarm Quality Assessment Scale for adverse events. 2012 24. Viswanathan M, Ansari M, Berkman N. Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Rockville (MD): Agency for Healthcare Research and Quality (US); Mar 8, 2012. [October 6, 2015]. Assessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions. [Internet] 2008-. Available from: http://www​.ncbi.nlm.nih​.gov/books/NBK91433/ 25. Andersson C, Olesen JB, Hansen PR, et al. Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study. Diabetologia. 2010;53(12):2546–2553. [PubMed] 26. Eurich DT, Majumdar SR, McAlister FA, Tsuyuki RT, Johnson JA. Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care. 2005;28(10):2345–2351. [PubMed] 27. Weir DL, McAlister FA, Senthilselvan A, Minhas-Sandhu JK, Eurich DT. Sitagliptin use in patients with diabetes and heart failure: a population-based retrospective cohort study. JACC Heart Fail. 2014;2(6):573–582. [PubMed] 28. Wang Z. Converting odds ratio to relative risk in cohort studies with partial data information. Journal of Statistical Software. 2013;55(5):1–11. 29. Dechartres A, Altman DG, Trinquart L, Boutron I, Ravaud P. Association between analytic strategy and estimates of treatment outcomes in meta-analyses. JAMA. 2014;312(6):623–630. [PubMed] 30. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188. [PubMed] 31. Knapp G, Hartung J. Improved tests for a random effects meta-regression with a single covariate. Stat Med. 2003;22(17):2693–2710. [PubMed] 32. Balshem H, Helfand M, Schunemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401–406. [PubMed] 33. Richy FF, Sabido-Espin M, Guedes S, Corvino FA, Gottwald-Hostalek U. Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study. Diabetes Care. 2014;37(8):2291–2295. [PubMed] 34. Eppenga WL, Lalmohamed A, Geerts AF, et al. Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study. Diabetes Care. 2014;37(8):2218–2224. [PubMed] 35. Romero SP, Andrey JL, Garcia-Egido A, et al. Metformin therapy and prognosis of patients with heart failure and new-onset diabetes mellitus. A propensity-matched study in the community. Int J Cardiol. 2013;166(2):404–412. [PubMed] 36. Ito H, Ohno Y, Yamauchi T, Kawabata Y, Ikegami H. Efficacy and safety of metformin for treatment of type 2 diabetes in elderly Japanese patients. Geriatr Gerontol Int. 2011;11(1):55–62. [PubMed] 37. Sterner G, Elmståhl S, Frid A, et al. Renal function in a large cohort of metformin treated patients with type 2 diabetes mellitus. British Journal of Diabetes and Vascular Disease. 2012;12(5):227–231. 38. Zhang X, Harmsen WS, Mettler TA, et al. Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes. Hepatology. 2014;60(6):2008–2016. [PMC free article] [PubMed] 39. Becquemont L, Bauduceau B, Benattar-Zibi L, et al. Cardiovascular Drugs and Metformin Drug Dosage According to Renal Function in Non-Institutionalized Elderly Patients. Basic Clin Pharmacol Toxicol. 2015[PubMed] 40. Ekström N, Schiöler L, Svensson AM, et al. Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: A cohort study from the Swedish National Diabetes Register. BMJ Open. 2012;2:4. Article Number: e001076. [PMC free article] [PubMed] 41. Aguilar D, Chan W, Bozkurt B, Ramasubbu K, Deswal A. Metformin use and mortality in ambulatory patients with diabetes and heart failure. Circulation: Heart Failure. 2011;4(1):53–58. [PMC free article] [PubMed] 42. Masoudi FA, Inzucchi SE, Wang Y, Havranek EP, Foody JM, Krumholz HM. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study. Circulation. 2005;111(5):583–590. [PubMed] 43. Morgan CL, Mukherjee J, Jenkins-Jones S, Holden SE, Currie CJ. Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational study. Diabetes Obes Metab. 2014;16(10):957–962. [PubMed] 44. Roussel R, Travert F, Pasquet B, et al. Metformin use and mortality among patients with diabetes and atherothrombosis. Arch Intern Med. 2010;170(21):1892–1899. [PubMed] 45. Evans JM, Doney AS, AlZadjali MA, et al. Effect of Metformin on mortality in patients with heart failure and type 2 diabetes mellitus. Am J Cardiol. 2010;106(7):1006–1010. [PubMed] 46. Inzucchi SE, Masoudi FA, Wang Y, et al. Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project. Diabetes Care. 2005;28(7):1680–1689. [PubMed] 47. Shah DD, Fonarow GC, Horwich TB. Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes. J Card Fail. 2010;16(3):200–206. [PMC free article] [PubMed] 48. Tinetti ME, McAvay G, Trentalange M, Cohen AB, Allore HG. Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study. BMJ. 2015;351:h4984. [PMC free article] [PubMed] 49. Ampuero J, Ranchal I, Nunez D, et al. Metformin inhibits glutaminase activity and protects against hepatic encephalopathy. PloS One. 2012;7(11):e49279. [PMC free article] [PubMed] 50. Nkontchou G, Cosson E, Aout M, et al. Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients. J Clin Endocrinol Metab. 2011;96(8):2601–2608. [PubMed] 51. Blonde L, Rosenstock J, Mooradian AD, Piper BA, Henry D. Glyburide/metformin combination product is safe and efficacious in patients with type 2 diabetes failing sulphonylurea therapy. Diabetes Obes Metab. 2002;4(6):368–375. [PubMed] 52. Cryer DR, Nicholas SP, Henry DH, Mills DJ, Stadel BV. Comparative outcomes study of metformin intervention versus conventional approach the COSMIC Approach Study. Diabetes Care. 2005;28(3):539–543. [PubMed] 53. Garber AJ, Larsen J, Schneider SH, Piper BA, Henry D. Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes. Diabetes Obes Metab. 2002;4(3):201–208. [PubMed] 54. Gregorio F, Ambrosi F, Manfrini S, et al. Poorly controlled elderly Type 2 diabetic patients: the effects of increasing sulphonylurea dosages or adding metformin. Diabet Med. 1999;16(12):1016–1024. [PubMed] 55. Hanefeld M, Brunetti P, Schernthaner GH, Matthews DR, Charbonnel BH. One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes. Diabetes Care. 2004;27(1):141–147. [PubMed] 56. Marre M, Howlett H, Lehert P, Allavoine T. Improved glycaemic control with metformin-glibenclamide combined tablet therapy (Glucovance) in Type 2 diabetic patients inadequately controlled on metformin. Diabet Med. 2002;19(8):673–680. [PubMed] 57. Schweizer A, Dejager S, Bosi E. Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, randomized trial. Diabetes Obes Metab. 2009;11(8):804–812.[PubMed] 58. Bannister CA, Holden SE, Jenkins-Jones S, et al. Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab. 2014;16(11):1165–1173. [PubMed] 59. Bodmer M, Meier C, Krahenbuhl S, Jick SS, Meier CR. Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis. Diabetes Care. 2008;31(11):2086–2091. [PMC free article] [PubMed] 60. Huizinga MM, Roumie CL, Greevy RA, et al. Glycemic and weight changes after persistent use of incident oral diabetes therapy: a Veterans Administration retrospective cohort study. Pharmacoepidemiol Drug Saf. 2010;19(11):1108–1112. [PubMed] 61. Leung S, Mattman A, Snyder F, Kassam R, Meneilly G, Nexo E. Metformin induces reductions in plasma cobalamin and haptocorrin bound cobalamin levels in elderly diabetic patients. Clin Biochem. 2010;43(9):759–760. [PubMed] 62. Roumie CL, Hung AM, Greevy RA, et al. Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study. Ann Intern Med. 2012;157(9):601–610. [PMC free article] [PubMed] 63. Wang CP, Lorenzo C, Espinoza SE. Frailty Attenuates the Impact of Metformin on Reducing Mortality in Older Adults with Type 2 Diabetes. J Endocrinol Diabetes Obes. 2014;2(2) [PMC free article] [PubMed] 64. Tzoulaki I, Molokhia M, Curcin V, et al. Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database. BMJ. 2009;339:b4731. [PMC free article] [PubMed] 65. American Diabetes Association. Standards of Medical Care in Diabetes--2016. [June 30, 2016]. Available at: http://care​.diabetesjournals​.org/content/39/Supplement_1. 66. Bolen S, Tseng E, Hutfless S, et al. Diabetes Medications for Adults With Type 2 Diabetes: An Update.Rockville (MD): Agency for Healthcare Research and Quality (US); 2016. AHRQ Comparative Effectiveness Reviews. 67. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38(1):140–149. [PubMed] 68. Tuot DS, Lin F, Shlipak MG, et al. Potential impact of prescribing metformin according to eGFR rather than serum creatinine. Diabetes Care. 2015;38(11):2059–2067. [PMC free article] [PubMed] 69. Palmer SC, Mavridis D, Nicolucci A, et al. Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis. Jama. 2016;316(3):313–324. [PubMed] 70. MacDonald MR, Eurich DT, Majumdar SR, et al. Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database. Diabetes Care. 2010;33(6):1213–1218. [PMC free article] [PubMed] 71. U.S. Department of Veterans Affairs. Office of Research & Development. VA CSP Study No. 597: Diuretic Comparison Project. [August 29, 2016]. Available at: http://www​.research.va​.gov/programs/csp/597/ 72. Canadian Diabetes Association. Clinical Practice Guidelines: Pharmacotherapy for Type 2 Diabetes. [June 30, 2016]. Available at: http://guidelines​.diabetes​.ca/bloodglucoselowering​/pharmacologyt2-(1) 73. Gong L, Goswami S, Giacomini KM, Altman RB, Klein TE. Metformin pathways: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics. 2012;22(11):820–827. [PMC free article] [PubMed] 74. Weir MA, Gomes T, Mamdani M, et al. Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: a population-based nested case-control study. Nephrol Dial Transplant. 2011;26(6):1888–1894. [PubMed]      •••SUPPORT OUR SPONSORS•••   (COACHING) Alex - www.theprepcoach.com   (FREE OPEN FORUM w/ EXCLUSIVE VIDEOS) http://www.theprepcoachforum.com   (SUPPLEMENTS) www.projectad.me___use discount code “BFR25” to save off your order!   (RESEARCH CHEMS) www.maresearchchems.net___use discount code “alex15” to save off your order!   (SPECIALTY SUPPS) www.masupps.com___use discount code “alex20” to save off your order!   (INJECTABLE L-CARNITINE) www.synthetek.com___use discount code “alexkikel” to save off your order!   (BULK SUPPLEMENTS) www.truenutrition.com___use discount code “AXK5” to save off your order!       •••FIND THE EPISODES•••   ITUNES:https://itunes.apple.com/us/podcast/beastfitness-radios-podcast/id1065532968   LIBSYN:http://beastfitnessradio.libsyn.com   VIMEO: www.vimeo.com/theprepcoach        •••PREP COACH APPAREL•••   https://teespring.com/stores/the-prep-coach-apparel    

Diabetes medications can help you control your blood sugar levels and prevent diabetes-related complications. To receive more tips on how to manage your diabetes sign up for ADA’s free Living With Type 2 Diabetes program.

In this episode of #Dictations, Andy Rogers PA-C talks about understanding the medications used for Type 2 Diabetes, as well as how to reverse Type 2 Diabetes. This is a Part 2 conversation with Andy about diabetes, where he goes into more detail on how the different diabetes medications work.

Dr. Maisara Rahman shares how insulin works, if all diabetics need it and the different medications available to help control diabetes.

The number of medications available to treat diabetes continues to increase. Recently, there has been widespread interest in two classes of medications, the SGLT2 inhibitors and the GLP1 agonists. They have created quite the splash with improvements in cardiovascular outcomes in patients with type 2 diabetes. In this podcast...

The number of medications available to treat diabetes continues to increase. Recently, there has been widespread interest in two classes of medications, the SGLT2 inhibitors and the GLP1 agonists. They have created quite the splash with improvements in cardiovascular outcomes in patients with type 2 diabetes. In this podcast...

Session 08 Step 1 and Level 1 love to test the mechanisms or side effects of medications that treat diabetes. Follow along to test your knowledge of diabetic medications and side effects. Once again, we're joined by Dr. Andrea Paul, Chief Medical Officer at Board Vitals. Reminder to everyone is that you may know the diagnosis but the question is not going to be that simple. So be prepared for so many different levels of questions and knowledge that you have to know. Use the promo code BOARDROUNDS to save 15% off their QBanks. [02:00] Diabetes Medications There are lots of medications for diabetes so it makes it extra complicated and they have their own interesting set of side effects and mechanisms of action that you want to know because they're commonly tested. As you're studying medications, first look at the overarching category. You don't have to remember every single medication within that overarching category. But in some cases like insulin, it's helpful to know the different preparation because they may ask about short-acting or long-acting insulin preparation. But generally, other medications have the same mechanisms and side effects so you can combine those together and just remember by the generic names. Most often, what the test is going to be asking about is mechanism or side effect. [05:00] Question of the Week It's a 56-year-old man with adult-onset diabetes who's visiting his primary care physician. He's been on medication while controlled and his glucose levels have improved. But now, he is presenting with his glucose levels trending up over the last 6 months. His A1C trending up and they want to add a second medication. There's a worrisome side effect of the second medication and it's asking you to narrow down, looking at the different options of what you could add to what he's already on. So you need to think about which of those has a worrisome side effect. He's on Sulphonylurea and when you think about that category of medications, you start thinking that glucose normally triggers an insulin release from the pancreatic beta cells. They mimic the action of glucose so they close those channels in the cells and that depolarizes them which leads to insulin release. Then when you think about toxicity, that's the category of drugs where you think about disulfiram reaction and hypoglycemia. With insulin, if you take more than what's necessary, there's a worrisome side effect of hypoglycemia. Then you start thinking through which of the other categories have something that they would categorize as extremely worrisome. That would knock out things like hypoglycemia because that's the side effect of almost every antidiabetic medication. You'd start thinking down the path of severe toxicity and the only medication that has that is the Glitazone category. Those are the medications where their mechanism is they bind receptors that modulate insulin sensitivity. They will increase your insulin sensitivity and decrease gluconeogenesis, increase the number of insulin receptors. They're known for cardiovascular and hepatotoxicity which is something you have to remember about that category. If you look through all of the other diabetic medication categories, none of them have as worrisome or a severe side effect as that category does. [08:20] What's the Worrisome Effect? In this case, the answer is hepatotoxicity. The way you can narrow it down is knowing that he's already on a sulphonylurea and they're adding something that causes a very worrisome side effect. You can immediately narrow it down and find the medication in the list of options that fall into that category. Choices: Hypoglycemia Renal dysfunction Liver dysfunction Peripheral neuropathy Gastrointestinal dysfunction [09:30] Getting to Your Answer This is a two-step process where you have to both assume what the next medication to be added is and knowing which category has a worrisome side effect and then coordinating that side effect with the generic name of the medication within that category. It's a bit tricky but once you can cross out the other effects then it could lead you down the right path into the category they're asking for which is the Glitazone category. There are questions along the same lines where they don't say what medication was added to the patient and they come in with say, hepatotoxicity and just give you lab values indicating that. So that's an example of where they may give you a different option of medication and you'd have to identify the one that caused it. So you have to know the side effect as well as recognize the generic name. Not all categories for diabetes medications do have a common ending so there's some memorization required. But most of them have one or two different endings that you can remember. For instance, sulphonylureas tend to end in -ide or -mide. These are little things that can help you remember what category. But if you can remember the overarching categories, that will lead you down the right path where your memory might kick in and remember things. Specifically, the question is looking at adding a second medication and you can already cancel out one with the sulphonylurea. Then look down through the answer options. Just remember what the most severe side effect in each category is and be able to identify which one would be most worrisome or severe. [12:50] Brand Names The test doesn't look at brand names and it's nice there are these naming conventions. Brand names can be much more challenging to remember compared to generic names which have pretty repetitive patterns. In this case, besides insulin, most sulphonylureas and glitazones will have common endings you can remember. [13:30]  Strategies for Insulin-Specific Questions Just one thing to note since they like to ask the onset and peak for different types of insulin and just the mechanism. So you should be able to know the mechanism of how insulin works and that cycle in general. Lispro starts to act most rapidly, 15 minutes. Regular insulin is half an hour to an hour. NPH is 1-2 hours and Glargine where the onset is one hour but it actually doesn't peak. This is something they may ask as well. They tend to follow the same pattern for their peak so the more rapid-acting, Lispro, also peaks first and then the peak extends out later as they go through NPH and Glargine. They would usually look for the basic pharmacology and pharmacodynamics and kinetics of medication on Step 1. They'd be probably asking something about the onset or peak of different preparations rather than combining them. Links: Board Vitals (promo code BOARDROUNDS)

Michael Fralick and John Fralick, both general internists in Toronto, kick off The Rounds Table for the New Year.  They cover four articles in a rapid-fire style, including: angiotensin receptor-neprilysin inhibitors (ARNIs) in decompensated heart failure (HF), linagliptin and major cardiovascular events, reduced dietary salt intake in heart failure, and dapagliflozin and cardiovascular outcomes. Sacubitril/valsartan ... The post Salty or Sweet: ARNIs, Reduced Salt Intake in HF, and Cardiovascular Safety of Diabetes Medications appeared first on Healthy Debate.

Michael Fralick and John Fralick, both general internists in Toronto, kick off The Rounds Table for the New Year.  They cover four articles in a rapid-fire style, including: angiotensin receptor-neprilysin inhibitors (ARNIs) in decompensated heart failure (HF), linagliptin and major cardiovascular events, reduced dietary salt intake in heart failure, and dapagliflozin and cardiovascular outcomes. Sacubitril/valsartan ...The post Salty or Sweet: ARNIs, Reduced Salt Intake in HF, and Cardiovascular Safety of Diabetes Medications appeared first on Healthy Debate.

CKD And Diabetes: What Medications Are Affected By Your Stage Of Kidney Failure Podcast #80 Released on February 4, 2018 If you have diabetes and you have kidney failure, your amounts of medications or specific medication that you're taking may be affected. I want to go over some of that. There's a lot of information on […] The post Renal Diet Podcast 080 – CKD And Diabetes Medications appeared first on Renal Diet Menu Headquarters. Suggested Reading: Renal Diet Podcast 076 – Diet, More Important for Kidney Disease? Renal Diet Podcast 063 – Commonly Prescribed Medications Renal Diet Podcast 065 – Grapefruit, Kidney Disease, Medications

CKD And Diabetes: What Medications Are Affected By Your Stage Of Kidney Failure Podcast #80 Released on February 4, 2018 If you have diabetes and you have kidney failure, your amounts of medications or specific medication that you're taking may be affected. I want to go over some of that. There's a lot of information on […] The post Renal Diet Podcast 080 – CKD And Diabetes Medications appeared first on Renal Diet Menu Headquarters. Suggested Reading: Grapefruit and Kidney Disease, and Medications Renal Diet HQ Share – Weight Loss and Diabetes Renal Diet Podcast 076 – Diet, More Important for Kidney Disease?

Happy Monday Train Your Brain Podcast listeners! Today we are going to discuss a controversial new treatment plan for the prevention of diseases like Alzheimer’s and Parkinson’s. Doctor Trayford explains that doctors are now prescribing diabetes medications as a way … Continue reading →

We are back! (Or your money back!) In this episode, Billy and Tina discuss the PharmaCare coverage status of different classes of diabetes medications. Sources: BC PharmaCare Formulary: https://pcbl.hlth.gov.bc.ca/pharmacare/benefitslookup/ BC PharmaCare Special Authority: http://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/pharmacare/prescribers/special-authority CDA Formulary Listings for Diabetes Medications in Canada by provinces and territories (Jan 2016): http://www.diabetes.ca/getmedia/c87009a8-29b6-4061-a52a-963d0b077e47/pt-formulary-listing-jan-18-2016.pdf.aspx *In case the link doesn’t work: pt-formulary-listing-jan-18-2016 Class drugs Other therapeutic […] The post Diabetes Medications and BC Coverage Information appeared first on Family Pharm Podcast.

Do certain type 2 diabetes medications lead to painful pancreatitis? And how do fat, protein, and high glycemic foods affect after-meal glucose levels in type 1 diabetes?

Do certain diabetes medications increase the risk of cancer? Plus, how to lose weight using an online weight-loss program.

http://www.cheftimothymoore.com, How to stop taking DIABETES medication in the nest 90 day's and regain those 10 years you lost. These word I can't stop taking my insulin, I'll get sick. This power pack podcast will change the way you look at diabetes forever. To get free information just text eathealthy your  name and email to 58885

In this episode, we discuss newly approved agents for diabetes mellitus: Afrezza (inhaled human insulin), SGLT2 inhibitors (Invokana, Farxiga, Jardiance), and long-acting GLP-1 agonists (Bydureon, Tanzeum).

Katherine Jones, MD, an endocrinologist, explains the types of diabetes, the connection to obesity, the medical consequences of diabetes, and the relative roles of medication use and lifestyle changes.

Mr. Divabetic interviews John W. Griffin, Jr., Chair of the American Diabetes Association and Roba Whitely, Executive Director of Together RX Access about the partnership that offers prescription medication discounts to people living with diabetes.

Guest: Vivian Fonseca, MD, FRCP Host: Steven Edelman, MD SGLT2 is responsible for glucose re-absorption in the kidney and decreasing SGLT2 function promotes glucose excretion to help reduce blood sugar levels, making it an attractive area for the treatment of diabetes. Join host Dr. Steven Edelman and his guest, professor of medicine at Tulane University, Dr. Vivian Fonseca, as they discuss the new class of medications being investigated for the treatment of type-2 diabetes.

Guest: Rita K. Cydulka, MD, MS Host: Shira Johnson, MD Seven percent of the adult population has diabetes, and these patients often present to primary care and emergency department physicians. What do you need to know about the medications these patients may already be taking, or that they may require once they're under your care? Understanding the effects, as well as potential complications, of the most current diabetes medications and devices is crucial when treating patients who have diabetes. Dr. Rita Cydulka, professor and vice-chair of the department of emergency medicine at Case Western Reserve University, joins host Dr. Shira Johnson to highlight the new medications and devices for managing diabetes. She also describes real-life presentations of patients who may be having problems with glucose management.

Guest: Rita K. Cydulka, MD, MS Host: Shira Johnson, MD Seven percent of the adult population has diabetes, and these patients often present to primary care and emergency department physicians. What do you need to know about the medications these patients may already be taking, or that they may require once they're under your care? Understanding the effects, as well as potential complications, of the most current diabetes medications and devices is crucial when treating patients who have diabetes. Dr. Rita Cydulka, professor and vice-chair of the department of emergency medicine at Case Western Reserve University, joins host Dr. Shira Johnson to highlight the new medications and devices for managing diabetes. She also describes real-life presentations of patients who may be having problems with glucose management.

What is the difference between semaglutide (ozempic) and tirzepatide (mounjaro) in outcomes and mechanism? How did we find out diabetes medications can help with weight loss?Sponsors: Post Investment: Real Estate Syndications || Hellofresh  Show Notes & Transcript02:08 Framework for thinking about obesity03:42 History of obesity treatment06:29 Gila monsters and GLP and GIP mechanisms08:29 Story of how medications for diabetes were found to have a weight loss benefit12:50 SURMOUNT-1 trialTags: IMCore, CoreIM, primary care, cardiology, nurse practitioner, pharmacist, physician assistantFind the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840Our Sponsors:* Use code 50COREIM for HelloFresh, America's #1 Meal: http://hellofresh.com/50COREIMAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy